0000950170-24-029523.txt : 20240311 0000950170-24-029523.hdr.sgml : 20240311 20240311194336 ACCESSION NUMBER: 0000950170-24-029523 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240308 FILED AS OF DATE: 20240311 DATE AS OF CHANGE: 20240311 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hunt Anthony CENTRAL INDEX KEY: 0001606030 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14656 FILM NUMBER: 24739797 MAIL ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02452 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REPLIGEN CORP CENTRAL INDEX KEY: 0000730272 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 042729386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 7814499560 MAIL ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 4 1 ownership.xml 4 X0508 4 2024-03-08 0000730272 REPLIGEN CORP RGEN 0001606030 Hunt Anthony C/O REPLIGEN CORPORATION 41 SEYON ST., BLDG 1, STE 100 WALTHAM MA 02453 false true false false Chief Executive Officer true Common Stock 2024-03-08 4 M false 1 16.55 A 201956 D Common Stock 2024-03-08 4 S false 3377 195.49 D 198579 D Common Stock 2024-03-08 4 S false 6228 196.32 D 192351 D Common Stock 2024-03-08 4 S false 1666 197.39 D 190685 D Common Stock 2024-03-08 4 S false 1347 198.55 D 189338 D Common Stock 2024-03-08 4 S false 1822 199.53 D 187516 D Common Stock 2024-03-08 4 S false 1305 200.56 D 186211 D Common Stock 2024-03-08 4 S false 806 201.75 D 185405 D Common Stock 2024-03-08 4 S false 156 202.55 D 185249 D Stock Option (Right to Buy) 16.55 2024-03-08 4 M false 1 0.00 A 2024-05-05 Common Stock 1 0 D Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on November 9, 2023. $195.49 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.90 to $195.88, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. $196.32 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $195.95 to $196.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. $197.39 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $196.98 to $197.96, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. $198.55 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.05 to $198.94, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. $199.53 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.13 to $200.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. $200.56 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.18 to $200.76, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. $201.75 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.21 to $202.17, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. $202.55 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.41 to $202.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. This option is fully vested and exercisable. /s/ Kimberly Brown (Attorney in Fact) 2024-03-11